You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

belimumab

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systemic Lupus Erythematosus Trial (Belimumab, Standard of care)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Belimumab
  • Standard of care
  • (no location specified)
Jun 14, 2023

Belimumab In Prevention of LN

Not yet recruiting
  • Whether Belimumab Could Reduce 2-year Risk of New-onset Lupus Nephritis
  • Belimumab
  • (no location specified)
Oct 14, 2022

Telitacicept and Belimumab in Active Lupus Nephritis in Real

Not yet recruiting
  • Lupus Nephritis
  • +2 more
  • (no location specified)
Oct 18, 2022

Lupus Erythematosus, Systemic Trial in Beijing (Belimumab, Standard of care)

Completed
  • Lupus Erythematosus, Systemic
  • Belimumab
  • Standard of care
  • Beijing, Dongcheng, China
    Peking Union Medical College hospital
Jul 5, 2022

Antiphospholipid Syndrome Trial in Turin (Belimumab)

Recruiting
  • Antiphospholipid Syndrome
  • Belimumab
  • Turin, Piedmont, Italy
    San Giovanni Bosco Hospital
May 20, 2022

Systemic Lupus Erythematosus Trial in Wilmington (belimumab)

Completed
  • Systemic Lupus Erythematosus
  • belimumab
  • Wilmington, North Carolina
  • +15 more
Jan 19, 2023

COPD, Emphysema Trial in Birmingham (Belimumab, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Emphysema
  • Belimumab
  • Placebo
  • Birmingham, Alabama
    UAB Lung Health Center
Apr 4, 2022

Systemic Lupus Erythematosus Trial in Beijing (Belimumab, Interleukin-2)

Recruiting
  • Systemic Lupus Erythematosus
  • Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Mar 24, 2022

Systemic Lupus Erythematosus Trial (Belimumab)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Belimumab
  • (no location specified)
Jan 12, 2022

Membranous Nephropathy, Nephrotic Syndrome Trial in Canada, United States (Belimumab, Placebo for Belimumab, Rituximab)

Recruiting
  • Membranous Nephropathy
  • Nephrotic Syndrome
  • Belimumab
  • +2 more
  • Birmingham, Alabama
  • +16 more
Sep 22, 2022

ANCA Associated Vasculitis, Granulomatosis With Polyangiitis Trial in United Kingdom (Belimumab, Rituximab, Prednisolone)

Active, not recruiting
  • ANCA Associated Vasculitis
  • Granulomatosis With Polyangiitis
  • Belimumab
  • +2 more
  • Cambridge, United Kingdom
  • +5 more
Feb 21, 2022

Systemic Lupus Erythematosus Trial (Belimumab, Standard therapy)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Belimumab
  • Standard therapy
  • (no location specified)
Sep 29, 2021

Multiple Sclerosis Trial in Baltimore (Belimumab, Short-course Ocrelizumab, Continued Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • Belimumab
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 7, 2021

Vasculitis, Cryoglobulinemia Trial (Belimumab, Placebo)

Not yet recruiting
  • Vasculitis
  • Cryoglobulinemia
  • Belimumab
  • Placebo
  • (no location specified)
Nov 9, 2020

Transcriptional and Immine Parameters of Response to Belinumab

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Belimumab
  • (no location specified)
Dec 4, 2020

Systemic Lupus Erythematosus Trial in Worldwide (Belimumab, Rituximab, Rituximab-)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • Belimumab
  • +5 more
  • Birmingham, Alabama
  • +78 more
Mar 25, 2022

Lupus Nephritis Trial in United States (Rituximab, Cyclophosphamide, Prednisone)

Completed
Has Results
  • Lupus Nephritis
  • Rituximab
  • +6 more
  • Birmingham, Alabama
  • +14 more
Nov 13, 2020

Systemic Lupus Erythematosus Trial in Shanghai, Suzhou (Belimumab)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • Belimumab
  • Shanghai, China
  • +1 more
Mar 17, 2020

Myositis Trial in Great Neck (Belimumab, Placebo)

Unknown status
  • Myositis
  • Belimumab
  • Placebo
  • Great Neck, New York
    Northwell Health Divison of Rheumatology
Sep 6, 2019

Systemic Lupus Erythematosus Trial in Worldwide (Belimumab)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • Belimumab
  • Los Angeles, California
  • +19 more
Jan 21, 2020

Systemic Lupus Erythematosus Trial in Japan, Korea, Republic of (Belimumab)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • Belimumab
  • Chiba, Japan
  • +26 more
Mar 17, 2020

Renal Transplant Rejection Trial in Cincinnati (belimumab, Bortezomib, Rituximab)

Completed
  • Renal Transplant Rejection
  • belimumab
  • +3 more
  • Cincinnati, Ohio
  • +1 more
Apr 19, 2019

Systemic Lupus Erythematosus Trial in China, Japan, Korea, Republic of (Belimumab, Placebo)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • Belimumab
  • Placebo
  • Hefei, Anhui, China
  • +46 more
Sep 20, 2019

Systemic Lupus Erythematosus Trial in Worldwide (belimumab)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • belimumab
  • Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • +109 more
Nov 19, 2019

Glomerulonephritis, Membranous Trial in United Kingdom (belimumab)

Completed
Has Results
  • Glomerulonephritis, Membranous
  • belimumab
  • Exeter, Devon, United Kingdom
  • +7 more
Sep 12, 2017